Two Sigma Advisers
CHTP

Two Sigma Advisers’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Two Sigma Advisers’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-28,100
Closed -$124K – 2726
2013
Q4 		$124K Buy
+28,100
New +$95K ﹤0.01% 2194

Other funds holding CHTP

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GH
Green Holdings Hamilton, Bermuda $9.16M AUM 15.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers's CHTP Position: Q1 2014 in Review

Two Sigma Advisers sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q1 2014, closing a stake of 28,100 shares — an estimated $124K sold.

Two Sigma Advisers first reported a position in CHTP in Q4 2013 and held it in 1 quarter. The position peaked at $124K in Q4 2013. 85 funds tracked by Wall St. Rank hold CHTP as of Q1 2014.

  • Two Sigma Advisers reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q1 2014 after selling out during the quarter.
  • Two Sigma Advisers sold 28,100 CHELSEA THERAPEUTICS INT'L LTD shares in Q1 2014, an estimated $124K.
  • Two Sigma Advisers first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q4 2013 and held it in 1 quarter.
  • Two Sigma Advisers's CHELSEA THERAPEUTICS INT'L LTD position peaked at $124K in Q4 2013.
  • 85 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q1 2014.

Based on Two Sigma Advisers's 13F filing for Q1 2014, filed 15 May 2014.